1. Home
  2. OESX vs CRBU Comparison

OESX vs CRBU Comparison

Compare OESX & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion Energy Systems Inc.

OESX

Orion Energy Systems Inc.

N/A

Current Price

$12.12

Market Cap

51.3M

ML Signal

N/A

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

N/A

Current Price

$0.41

Market Cap

48.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OESX
CRBU
Founded
1996
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.3M
48.5M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
OESX
CRBU
Price
$12.12
$0.41
Analyst Decision
Strong Buy
Buy
Analyst Count
2
6
Target Price
★ $36.50
$5.75
AVG Volume (30 Days)
33.0K
★ 2.6M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 3.64
EPS
★ 0.27
N/A
Revenue
★ $86,306,000.00
N/A
Revenue This Year
$17.95
$114.75
Revenue Next Year
$10.38
N/A
P/E Ratio
$50.11
★ N/A
Revenue Growth
★ 8.26
N/A
52 Week Low
$8.58
$0.40
52 Week High
$31.65
$2.49

Technical Indicators

Market Signals
Indicator
OESX
CRBU
Relative Strength Index (RSI) 20.95 26.66
Support Level $8.98 N/A
Resistance Level $21.13 $0.58
Average True Range (ATR) 1.51 0.04
MACD -0.79 0.02
Stochastic Oscillator 8.66 2.25

Price Performance

Historical Comparison
OESX
CRBU

About OESX Orion Energy Systems Inc.

Orion Energy Systems Inc provide light emitting diode (LED) lighting systems, wireless Internet of Things (IoT) enabled control solutions, commercial and industrial electric vehicle charging infrastructure solutions and lighting and electrical maintenance services. It help its customers achieve their sustainability, energy savings and carbon footprint reduction goals through technology and exceptional service. It sell its products and services into many vertical markets within the broader commercial and industrial market segment. Primary verticals include box retail, manufacturing, warehousing/logistics, federal and municipal government, healthcare and schools. It has three segments Lighting, Maintenance, and EV segment. It generates majority of revenue from Lighting segment.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

Share on Social Networks: